Quick Takeaways
- Orca Capital AG filed SCHEDULE 13G/A for Phio Pharmaceuticals Corp. Common Stock, par value $0.0001 per share (PHIO).
- Disclosed ownership: 4.9%.
- Date of event: 08 Dec 2025.
Orca Capital AG - 08 Dec 2025 SCHEDULE 13G/A Report for Phio Pharmaceuticals Corp. Common Stock, par value $0.0001 per share (PHIO)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- PHIO
- Shares outstanding
- 10,994,020 shares
- Disclosed Ownership
- 538,707 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Dec 2025, 16:30:13 UTC
- Date of event
- 08 Dec 2025
- Previous filing
- 24 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Orca Capital AG disclosed 4.9% ownership in Phio Pharmaceuticals Corp. Common Stock, par value $0.0001 per share (PHIO) on 08 Dec 2025."
What Changed
- Previous schedule filing date: 24 Nov 2025.
- Current filing was accepted on 11 Dec 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 4.9% | 538,707 | 538,707 | 0 | /s/ Thomas Konig | Thomas Konig/Director |